VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,844,000 | +39.9% | 165,424 | -4.2% | 0.96% | +37.2% |
| Q1 2018 | $2,748,000 | -14.2% | 172,600 | +12.0% | 0.70% | +0.9% |
| Q4 2017 | $3,202,000 | +2.8% | 154,100 | -29.1% | 0.69% | -2.9% |
| Q3 2017 | $3,114,000 | -22.6% | 217,300 | -6.5% | 0.71% | -21.5% |
| Q2 2017 | $4,022,000 | +71.7% | 232,500 | +9.5% | 0.91% | +73.3% |
| Q1 2017 | $2,342,000 | -22.6% | 212,300 | +1.9% | 0.52% | -36.3% |
| Q4 2016 | $3,024,000 | +24.3% | 208,300 | +110.2% | 0.82% | +21.1% |
| Q3 2016 | $2,433,000 | +7.3% | 99,100 | -12.0% | 0.68% | -2.9% |
| Q2 2016 | $2,267,000 | +95.9% | 112,600 | +155.9% | 0.70% | +113.1% |
| Q1 2016 | $1,157,000 | +48.7% | 44,000 | +1157.1% | 0.33% | +58.5% |
| Q2 2015 | $778,000 | – | 3,500 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |